Specializing in dermatological safety and efficacy testing, IRSI is a leader in biophysical instrumental analysis of the effects of test products on human skin condition. Additionally, IRSI has phase I-IV Rx and OTC trial experience in numerous other clinical indications including acid indigestion, diabetes, weight loss, constipation, common cold/cough, smoking cessation, pediatric safety testing, and odor threshold tolerance.
Specializing in dermatological safety and efficacy testing, IRSI is a leader in biophysical instrumental analysis of the effects of test products on human skin condition. Additionally, IRSI has phase I-IV Rx and OTC trial experience in numerous other clinical indications including acid indigestion, diabetes, weight loss, constipation, common cold/cough, smoking cessation, pediatric safety testing, and odor threshold tolerance.
Company Information
- Industry
- Research
- Company Type
- Nonprofit
- Founded
- 1977
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- 222 Grace Church St New York Port Chester
- City
- New York
- Region
- New York
- Postal Code
- 10573
- Country
- United States